![این مقاله در پایگاه ساینس دایرکت منتشر شده است Elsevier - ScienceDirect - الزویر - ساینس دایرکت](/assets/img/Elsevier-Logo.png)
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
Keywords: urinary bladder, overactive; urinary incontinence; onabotulinumtoxinA; quality of life; urinary tract infectionsAE, adverse event; CIC, clean intermittent catheterization; MID, minimally important difference; OAB, overactive bladder syndrome; PVR, post-vo